Michael Curry, MA, MS

Research Biostatistician II

Epidemiology & Biostatistics
Directory
Epidemiology
Biostatistics
Health Outcomes
Computational Oncology
Administrative Resources
Departmental Newsletter
Career Opportunities
Quantitative Sciences Undergraduate Research Experience (QSURE)
Software
Bridge to Biostats

Michael Curry, MA, MS

Research Biostatistician II

Share
Share
Michael Curry

Email

[email protected]

Education

Northwestern University

Current Research Interest

As a biostatistician at Memorial Sloan Kettering Cancer Center, Michael collaborates with physicians and completes statistical analyses for studies involving large observational databases such as the NCI’s Surveillance and Epidemiology End Results Program (SEER) registry linked to Medicare data, NCDB, VolPACT, and other observational databases. Studies are generally focused on describing real-world trends in cancer care and comparing outcomes for cancer treatments. In addition to these data sources, he has been working with childhood cancer survivor study (CCSS) data describing long-term effects of cancer in the pediatric population. Along with working on real-world data analyses, Michael is the data custodian for large registry databases at MSK and ensures PIs are adhering to IRB protocols and data use agreements.

Publications

  1. Nobel TB, Curry M, Gennarelli R, Jones DR, Molena D. Higher clinical suspicion is needed for prompt diagnosis of esophageal adenocarcinoma in young patients. (2019). Journal of Thoracic cardiovascular surgery. DOI: 10.1016/j.jtcvs.2019.03.095.
  2. Auffenberg GB, Curry M, Gennarelli R, Blum KA, Elkin E, Russo P. Comparison of Cancer-specific Outcomes following Minimally-Invasive and Open Surgical Resection of Early-Stage Kidney Cancer from a National Cancer Registry. (2019). Journal of Urology. doi: 10.1097/JU.0000000000000741.
  3. Green, A., Curry, M., Mailinkody, S., Bach, P. Assessment of Outcomes Related to use of Newly Approved Oncology Drugs in Medicare Beneficiaries. JAMA Open Network (2021 in press).
  4. Curry, M., et al. High hospital volume is associated with more consistent long-term mortality rates. JHMHP. (2021) Epub ahead of print.
  5. Lipitz-Snyderman A, Vater L, Curry M, Li D, Rubin DM, Radzyner M, Duck E, Bach PB, Schenker Y. Cancer hospital advertising and outcomes: trust the messenger? Lancet Oncol. 2019 Jun;20(6):760-762. doi: 10.1016/S1470-2045(19)30316-X. PMID: 31162089; PMCID: PMC7539685.